Masters of Health Magazine September 2018 - Page 43

A poisonous cocktail of glyphosate, heavy metals and fluoride all work to block the activity of magnesium and other essential trace elements. However, because magnesium in particular is the essential electrolyte involved in mitochondrial metabolism of ATP, and therefore protein synthesis and enzyme activity, its deficiency is at the root of this environmental toxic assault. Starved of energy, cells die. Over-exposure to glyphosate, heavy metals and fluoride is the proverbial elephant in the living room pointing to the exponential rise of degenerative diseases like diabetes, renal failure, heart disease, cancer, auto-immune disorders, autism spectrum disorder, alzheimers, parkinsons, dementia and cancer.

Have we learned any lessons yet?

In March 2015 the Agency for Research on Cancer, Lyon, France, a department of the World Health Organization, classified glyphosate (the active ingredient in Monsanto’s Roundup) as ‘probably carcinogenic to humans’. The evidence that glyphosate caused cancer in animals was considered ‘sufficient’ and the evidence concerning the genotoxicity of the product (ability to damage DNA) was considered ‘strong’. Various scientific studies have also shown the ability of glyphosate to induce genetic damage, oxidative stress in cells and damage to liver by inhibiting metabolic processes. [1]

Fast forward three years: In a ground-breaking decision on August 10, 2018, a court in California ordered Monsanto to pay US$289 million in damages to Dewayne Johnson, a school grounds keeper who had alleged Monsanto's glyphosate-based weed-killers, including Roundup, caused his cancer.

Lawyers are now scrambling to take advantage of this precedent to represent a large cohort of further damages claims. Bayer’s shares had plummeted in value following the announcement, as they had recently purchased Monsanto for a reported 63 billion dollars. Bayer may however not be so concerned about Monsanto’s legal woes, as they apparently intend to ditch the name Monsanto in the not-to-distant future. The acquisition of Monsanto’s assets will leave Bayer with a new global market dominance in control of nearly one third of the combined world market for seeds and pesticides.

That’s not all! Bayer also happens to have an extensive pharmaceutical division. Its parent company had a long history in the manufacture of drugs, including Aspirin and Heroin, in the early part of last century. They were also involved in the chemical experimentation on prisoners of war in Nazi Germany.